Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela de Angelis

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
AIDS (London, England)|September 16, 2015
Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSMAndrew N Phillips, Valentina Cambiano, Alec Miners, et al.
The Lancet. Infectious Diseases|August 30, 2021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort studyKatherine A Twohig, Tommy Nyberg, Asad Zaidi, et al.
BMC Public Health|April 16, 2020
Forecasting the 2017/2018 seasonal influenza epidemic in England using multiple dynamic transmission models: a case studyPaul J Birrell, Xu-Sheng Zhang, Alice Corbella, et al.
The Journal of Infectious Diseases|February 20, 2022
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant SublineagesTommy Nyberg, Katie Harman, Asad Zaidi, et al.
The International Journal on Drug Policy|November 16, 2025
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United KingdomHolly D Mitchell, India Clancy, Daniela De Angelis, et al.
Royal Society Open Science|July 30, 2024
Combining models to generate consensus medium-term projections of hospital admissions, occupancy and deaths relating to COVID-19 in EnglandHarrison Manley, Thomas Bayley, Gabriel Danelian, et al.
The International Journal on Drug Policy|June 28, 2024
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UKPantelis Samartsidis, Ross J Harris, John Dillon, et al.
Epidemics|February 18, 2022
Challenges in estimation, uncertainty quantification and elicitation for pandemic modellingBen Swallow, Paul Birrell, Joshua Blake, et al.
The Lancet Regional Health. Europe|December 19, 2023
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohortPeter D Kirwan, Victoria J Hall, Sarah Foulkes, et al.
BMC Medicine|March 27, 2024
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohortElisabeth Dietz, Emma Pritchard, Koen Pouwels, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
AIDS (London, England)|September 16, 2015
Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSMAndrew N Phillips, Valentina Cambiano, Alec Miners, et al.
The Lancet. Infectious Diseases|August 30, 2021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort studyKatherine A Twohig, Tommy Nyberg, Asad Zaidi, et al.
BMC Public Health|April 16, 2020
Forecasting the 2017/2018 seasonal influenza epidemic in England using multiple dynamic transmission models: a case studyPaul J Birrell, Xu-Sheng Zhang, Alice Corbella, et al.
The Journal of Infectious Diseases|February 20, 2022
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant SublineagesTommy Nyberg, Katie Harman, Asad Zaidi, et al.
The International Journal on Drug Policy|November 16, 2025
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United KingdomHolly D Mitchell, India Clancy, Daniela De Angelis, et al.
Royal Society Open Science|July 30, 2024
Combining models to generate consensus medium-term projections of hospital admissions, occupancy and deaths relating to COVID-19 in EnglandHarrison Manley, Thomas Bayley, Gabriel Danelian, et al.
The International Journal on Drug Policy|June 28, 2024
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UKPantelis Samartsidis, Ross J Harris, John Dillon, et al.
Epidemics|February 18, 2022
Challenges in estimation, uncertainty quantification and elicitation for pandemic modellingBen Swallow, Paul Birrell, Joshua Blake, et al.
The Lancet Regional Health. Europe|December 19, 2023
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohortPeter D Kirwan, Victoria J Hall, Sarah Foulkes, et al.
BMC Medicine|March 27, 2024
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohortElisabeth Dietz, Emma Pritchard, Koen Pouwels, et al.
Pageof 13